Literature DB >> 22004633

Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM.

F Egberts1, C Hartje, C Schafmayer, K C Kaehler, W von Schönfels, A Hauschild, T Becker, J H Egberts.   

Abstract

INTRODUCTION: When lymphatic metastasis occurs, surgery is the primary treatment modality in melanoma patients. Depending on the tumour stage, patients receive a completion lymph node dissection (CLND) when a positive sentinel node is detected. Patients with clinically evident disease of the regional lymph nodes are recommended to undergo a therapeutic lymph node dissection (TLND). The aim of this study was to assess the morbidity of CLND and TLND and to evaluate the Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity (POSSUM) for preoperative risk adjustment of postoperative morbidity.
METHODS: The hospital files of 143 patients who underwent CLND and TLND for malignant melanoma were analysed. The POSSUM score was used to predict morbidity rates after surgery for the total patient group as well as separated for CLND and TLND patients.
RESULTS: The overall complication rate was 28.0% and the mortality rate was 0%. The morbidity rate predicted by POSSUM was 32.9%, the mortality 8.3%. Morbidity in patients undergoing CLND was significantly higher with regard to overall wound complications compared with patients with TLND. In these subgroups, POSSUM failed to predict the rates precisely.
CONCLUSIONS: The POSSUM score predicted the morbidity of the total patient group accurately but failed to predict the rates in the TLND and CLND subgroups. Patients receiving CLND showed the highest morbidity rates. Preoperative sentinel lymph node biopsy therefore has more influence on postoperative morbidity than the physiological parameters represented in the POSSUM physiological score.

Entities:  

Mesh:

Year:  2011        PMID: 22004633      PMCID: PMC3604920          DOI: 10.1308/147870811X13137608455019

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  43 in total

Review 1.  Groin dissection.

Authors:  J Spratt
Journal:  J Surg Oncol       Date:  2000-04       Impact factor: 3.454

2.  CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections.

Authors:  T C Horan; R P Gaynes; W J Martone; W R Jarvis; T G Emori
Journal:  Infect Control Hosp Epidemiol       Date:  1992-10       Impact factor: 3.254

Review 3.  The effect of sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy.

Authors:  P J Paley; P R Johnson; L L Adcock; J A Cosin; M D Chen; J M Fowler; L B Twiggs; L F Carson
Journal:  Gynecol Oncol       Date:  1997-02       Impact factor: 5.482

4.  Positive deep nodes in the groin and survival in malignant melanoma.

Authors:  C P Karakousis; D L Driscoll
Journal:  Am J Surg       Date:  1996-04       Impact factor: 2.565

5.  Comparative audit of colorectal resection with the POSSUM scoring system.

Authors:  P M Sagar; M N Hartley; B Mancey-Jones; P C Sedman; J May; J Macfie
Journal:  Br J Surg       Date:  1994-10       Impact factor: 6.939

6.  A pilot study reporting outcomes for melanoma patients of a minimal access ilio-inguinal dissection technique based on two incisions.

Authors:  Andrew John Spillane; Monica Tucker; Sandro Pasquali
Journal:  Ann Surg Oncol       Date:  2010-12-14       Impact factor: 5.344

7.  Comparison of individual surgeon's performance. Risk-adjusted analysis with POSSUM scoring system.

Authors:  P M Sagar; M N Hartley; J MacFie; B A Taylor; G P Copeland
Journal:  Dis Colon Rectum       Date:  1996-06       Impact factor: 4.585

8.  Comparative vascular audit using the POSSUM scoring system.

Authors:  G P Copeland; D Jones; A Wilcox; P L Harris
Journal:  Ann R Coll Surg Engl       Date:  1993-05       Impact factor: 1.891

9.  Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis.

Authors:  D G Coit; A Rogatko; M F Brennan
Journal:  Ann Surg       Date:  1991-11       Impact factor: 12.969

10.  Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection.

Authors:  P Beitsch; C Balch
Journal:  Am J Surg       Date:  1992-11       Impact factor: 2.565

View more
  2 in total

Review 1.  A surgical perspective report on melanoma management.

Authors:  Brian D Wernick; Neha Goel; Francis Sw Zih; Jeffrey M Farma
Journal:  Melanoma Manag       Date:  2017-05-15

2.  Dissections of regional lymph nodes for treatment of skin cancer: predicting annual caseloads that will optimise outcomes.

Authors:  J K Dickson; A Davies; S Rahman; C Sethu; J R O Smith; A Orlando; D Ayers
Journal:  Ann R Coll Surg Engl       Date:  2015-01       Impact factor: 1.891

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.